By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ALS Therapy Development Institute 

215 First Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-441-7200 Fax: 617-441-7299


SEARCH JOBS


Industry
Biotechnology






Company News
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS 9/10/2013 10:23:08 AM
ALS Therapy Development Institute Adds Two Board Members 5/2/2013 7:50:58 AM
ALS Therapy Development Institute Release: FDA Approves Clinical Trial of TDI-132 (Gilenyaв) in ALS Patients 2/11/2013 9:16:16 AM
ALS Therapy Development Institute and To-BBB technologies BV Collaborate on Potential Treatments for Motor Neuron Disease 1/8/2013 10:10:07 AM
ALS Therapy Development Institute and Gladstone Institute Collaborate to Discover Potential ALS Treatments 12/4/2012 9:50:38 AM
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) (BIIB) and UCB Pharma (UCBJF.PK) to Investigate the Role of CD40L in ALS 12/19/2011 10:38:14 AM
U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS Therapy Development Institute During Gala Event this November 6/7/2011 9:38:38 AM
ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors 2/4/2011 9:52:54 AM
ALS Therapy Development Institute and Oxford BioMedica PLC (OXB.L) Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis 1/28/2010 7:57:44 AM
ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 5/4/2009 7:51:54 AM
12
//-->